Frederick, MD, United States of America

Bradley St Croix

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Bradley St Croix

Introduction

Bradley St Croix, an accomplished inventor based in Frederick, MD, has made significant contributions to the field of biotechnology with a focus on cancer treatment innovations. With a total of five patents to his name, his work is primarily centered around the development of novel therapeutic approaches utilizing anti-CD276 antibodies.

Latest Patents

Among his latest patents, St Croix has developed anti-CD276 antibodies that include polypeptides and proteins specifically designed to bind to and immunologically recognize CD276. His patents disclose a range of innovations, including chimeric antigen receptors (CARs), anti-CD276 binding moieties, nucleic acids, recombinant expression vectors, host cells, populations of cells, pharmaceutical compositions, and conjugates related to these polypeptides and proteins. Furthermore, he has introduced methods for detecting the presence of cancer or tumor vasculature in mammals, as well as methods for treating or preventing cancer and reducing tumor vasculature. These advancements reflect his commitment to pushing the boundaries of cancer therapeutics.

Career Highlights

Bradley St Croix has had a noteworthy career, having worked with reputable organizations, including Biomed Valley Discoveries, Inc. and the United States of America, represented by the Secretary, Department of Health and Human Services. His role in these organizations has allowed him to leverage his expertise in biochemistry and molecular biology to contribute to groundbreaking research and innovations in the medical field.

Collaborations

Throughout his career, St Croix has collaborated with prominent coworkers such as Zhongyu Zhu and Dimiter Stanchev Dimitrov. These collaborations have not only enhanced his research but also fostered a collaborative environment where innovation thrives.

Conclusion

Bradley St Croix's contributions to the field of biotechnology exemplify the spirit of innovation that drives the industry forward. His patented inventions provide hopeful advancements in cancer treatment, showcasing his dedication to improving patient outcomes and paving the way for future breakthroughs in medical science. As he continues his work, the impact of his inventions will be felt not only in laboratories but also in the lives of those battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…